Latest in Backer

Sort by

2 items

Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn

AI unit is boosted by first external funding round led by OpenAI-backer Thrive Capital
Financial Times - 1d
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
The New York Times - 1d